Clinical trial
Acid-Associated Heartburn Symptoms and Dose of Esomeprazole
NCT00206024 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00206024 |
|---|---|
| Title | Acid-Associated Heartburn Symptoms and Dose of Esomeprazole |
| Official title | A 4-week Study to Investigate the Relationship Between Resolution of Acid-Associated Heartburn Symptoms and Dose of Esomeprazole Magnesium |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heartburn |
| Intervention type | Drug |
| Interventions | Esomeprazole magnesium (Nexium) |
| Enrollment | 330 |
| Start date | Nov 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 19, 2010 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: